These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 2829326

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatic encephalopathy: a neurochemical disorder.
    Jones EA, Schafer DF.
    Prog Liver Dis; 1986; 8():525-40. PubMed ID: 2872697
    [No Abstract] [Full Text] [Related]

  • 3. The GABA hypothesis of the pathogenesis of hepatic encephalopathy: current status.
    Jones EA, Schafer DF, Ferenci P, Pappas SC.
    Yale J Biol Med; 1984; 57(3):301-16. PubMed ID: 6093394
    [Abstract] [Full Text] [Related]

  • 4. Benzodiazepine receptor ligands and hepatic encephalopathy: further unfolding of the GABA story.
    Jones EA.
    Hepatology; 1991 Dec; 14(6):1286-90. PubMed ID: 1660022
    [No Abstract] [Full Text] [Related]

  • 5. Theories of the pathogenesis of hepatic encephalopathy.
    Jones EA, Mullen KD.
    Clin Liver Dis; 2012 Feb; 16(1):7-26. PubMed ID: 22321462
    [Abstract] [Full Text] [Related]

  • 6. Pathophysiology of chronic hepatic encephalopathy.
    Bode JC, Schäfer K.
    Hepatogastroenterology; 1985 Dec; 32(6):259-66. PubMed ID: 3912312
    [No Abstract] [Full Text] [Related]

  • 7. The role of endogenous benzodiazepines in hepatic encephalopathy: animal studies.
    Jones EA, Yurdaydin C, Basile AS.
    Alcohol Alcohol Suppl; 1993 Dec; 2():175-80. PubMed ID: 7748296
    [Abstract] [Full Text] [Related]

  • 8. gamma-Aminobutyric acid (GABA) and hepatic encephalopathy: testing the validity of electroencephalographic evidence of the GABA hypothesis.
    Myslobodsky MS.
    Hepatogastroenterology; 1987 Apr; 34(2):58-64. PubMed ID: 3036678
    [Abstract] [Full Text] [Related]

  • 9. Plasma gamma aminobutyric acid concentrations provide evidence of different mechanisms in the pathogenesis of hepatic encephalopathy in acute and chronic liver disease.
    Levy LJ, Losowsky MS.
    Hepatogastroenterology; 1989 Dec; 36(6):494-8. PubMed ID: 2613171
    [Abstract] [Full Text] [Related]

  • 10. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K, Kowalczyk-Ziomek G, Konecki J.
    Wiad Lek; 2003 Dec; 56(11-12):560-3. PubMed ID: 15058165
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ammonia and GABA-ergic neurotransmission: interrelated factors in the pathogenesis of hepatic encephalopathy.
    Basile AS, Jones EA.
    Hepatology; 1997 Jun; 25(6):1303-5. PubMed ID: 9185743
    [No Abstract] [Full Text] [Related]

  • 13. Hepatic encephalopathy: pathogenesis.
    Bernardini AP.
    Arq Gastroenterol; 1988 Jun; 25 Spec No():57-61. PubMed ID: 3060059
    [No Abstract] [Full Text] [Related]

  • 14. Passage of amino acids and glucose across the blood-brain barrier in patients with hepatic encephalopathy.
    Knudsen GM, Schmidt J, Almdal T, Paulson OB, Vilstrup H.
    Hepatology; 1993 Jun; 17(6):987-92. PubMed ID: 8514271
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.